Corex Ban
- All
- News
- Videos
-
You Can Now Buy Vicks Action 500, Corex As Delhi Court Cancels Ban
Delhi High Court stayed on Thursday a government ban on 344 drugs that it deemed lacked therapeutic efficacy, after over six months of hearing more than 300 petitions filed by drugmakers against it.
-
Can You Buy Vicks Action 500, Corex? Delhi Court Verdict Today
The Delhi High Court is likely to pronounce today its verdict on 454 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
Pfizer Withdraws Corex Syrup, Extends Line To New Products
Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio.
-
Court Reserves Verdict On Pleas Against Ban On 344 Drugs
The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
Court Lifting Ban On FDC Drugs Against Patient Safety: Government
Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.
-
You Can Still Buy Vicks Action 500 Extra, Corex: No Ban For Now, Says Court
Popular drugs D'Cold, Vicks Action 500 Extra, Benadryl are among the 6,000-odd brands impacted by the government move to ban 344 fixed combination drugs.
-
After Pfizer, High Court Grants Relief to Abbott and Macleods
Pharma majors Abbott Healthcare and Macleods Pharmaceuticals on Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.
-
Pfizer, Abbott, Procter & Gamble Shares Hit By Drug Ban
Pfizer shares were headed for their second successive fall on Tuesday following following a ban on its Corex cough syrup. Pfizer shares sank 9 per cent yesterday.
-
Delhi High Court Grants Pfizer Temporary Relief on Cough Syrup Ban
Delhi High Court granted U.S. drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.
-
Like Corex, Cough Syrup Phensedyl Is Banned, Makers Will Go To Court
The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.
-
Corex, Popular Cough Syrup, Not Banned For Now, Says Court
The High Court will hear the case in a week. The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend prohibiting the sale and manufacture of 344 combination drugs blacklisted by a panel of experts.
-
High Court Grants Interim Stay On Stopping Sale Of Corex Cough Syrup
The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend ordering prohibition of the sale and manufacture of 344 combination drugs that a panel of experts found posed a risk to humans.
-
Health Ministry Bans 344 Fixed Dose Combination Drugs
Health Ministry has banned about 344 fixed dose combination drugs, including cough syrups compositions, saying they involve "risk" to humans and safer alternatives were available.
-
Pfizer Stops Selling Corex Cough Syrup In India After Ban
US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans.
-
Pfizer Stops Sale Of Corex Cough Syrup, Shares Tumble
Shares in the Indian units of US-based drugmakers Pfizer and Abbott Laboratories fell as much as 5 per cent on Monday after authorities imposed a ban on their codeine-based cough syrups, saying they posed a health risk.
-
You Can Now Buy Vicks Action 500, Corex As Delhi Court Cancels Ban
Delhi High Court stayed on Thursday a government ban on 344 drugs that it deemed lacked therapeutic efficacy, after over six months of hearing more than 300 petitions filed by drugmakers against it.
-
Can You Buy Vicks Action 500, Corex? Delhi Court Verdict Today
The Delhi High Court is likely to pronounce today its verdict on 454 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
Pfizer Withdraws Corex Syrup, Extends Line To New Products
Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio.
-
Court Reserves Verdict On Pleas Against Ban On 344 Drugs
The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
Court Lifting Ban On FDC Drugs Against Patient Safety: Government
Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.
-
You Can Still Buy Vicks Action 500 Extra, Corex: No Ban For Now, Says Court
Popular drugs D'Cold, Vicks Action 500 Extra, Benadryl are among the 6,000-odd brands impacted by the government move to ban 344 fixed combination drugs.
-
After Pfizer, High Court Grants Relief to Abbott and Macleods
Pharma majors Abbott Healthcare and Macleods Pharmaceuticals on Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.
-
Pfizer, Abbott, Procter & Gamble Shares Hit By Drug Ban
Pfizer shares were headed for their second successive fall on Tuesday following following a ban on its Corex cough syrup. Pfizer shares sank 9 per cent yesterday.
-
Delhi High Court Grants Pfizer Temporary Relief on Cough Syrup Ban
Delhi High Court granted U.S. drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.
-
Like Corex, Cough Syrup Phensedyl Is Banned, Makers Will Go To Court
The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.
-
Corex, Popular Cough Syrup, Not Banned For Now, Says Court
The High Court will hear the case in a week. The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend prohibiting the sale and manufacture of 344 combination drugs blacklisted by a panel of experts.
-
High Court Grants Interim Stay On Stopping Sale Of Corex Cough Syrup
The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend ordering prohibition of the sale and manufacture of 344 combination drugs that a panel of experts found posed a risk to humans.
-
Health Ministry Bans 344 Fixed Dose Combination Drugs
Health Ministry has banned about 344 fixed dose combination drugs, including cough syrups compositions, saying they involve "risk" to humans and safer alternatives were available.
-
Pfizer Stops Selling Corex Cough Syrup In India After Ban
US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans.
-
Pfizer Stops Sale Of Corex Cough Syrup, Shares Tumble
Shares in the Indian units of US-based drugmakers Pfizer and Abbott Laboratories fell as much as 5 per cent on Monday after authorities imposed a ban on their codeine-based cough syrups, saying they posed a health risk.
